Diet and Lifestyle interventions for glycemic control, cardiometabolic and cognitive health in type 2 diabetes.

Prof Jon Buckley (Centre Director)0 个研究点目标入组 60 人开始时间: 2013年1月4日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Poorly controlled type 2 diabetes (with a HbA1c level between 7-10%); overweight or obese (BMI, 25 kg/m2 and above); omnivorous; English as a First Language (different cognitive processes are applied when learning words from a non-native language)

•Subjects who report one of the following: known proteinuria, malignancy; liver, kidney, cardiovascular, respiratory, or gastrointestinal disease; uncontrolled hypertension; previous stroke; pregnancy or lactating; smoker (or smoking in the last 6months); musculoskeletal injury or joint or peripheral vascular disease sufficient to impede exercise; use of appetite suppressants or Orlistat (Xenical); retinopathy; inability to consume a high meat protein diet for 6 months; actively undertaking a weight loss program or report their weight is greater than 135kg (exceeds the capability for DEXA scanning to assess body composition); unable to participate in the trial for 6 months; taking medications for, or had a history of head/brain, neurological or psychiatric conditions, scores of <13 on the DemTect indicating mild cognitive impairment or dementia will be excluded.

发起方

Prof Jon Buckley (Centre Director)